Showing results (41-50 of 1,311) with videos related to
Sort By:
Pageof 132
Blood Pressure|April 21, 2017
Preserving Target-organ Function with Candesartan Cilexetil in Patients with HypertensionFaiez ZannadArchives of Cardiovascular Diseases|March 18, 2014
Heart failure with systolic dysfunction complicating acute myocardial infarction - differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: A post hoc substudy of the EPHESUS trialSylvain Carillo, Yan Zhang, Renaud Fay, et al.International Journal of Cardiology|February 1, 2022
Cardiac structure and function and quality of life associations in HFpEF: An analysis from TOPCAT-AmericasJoão Pedro Ferreira, Amil M Shah, Brian L Claggett, et al.International Journal of Cardiology|March 7, 2021
Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunctionSusan Stienen, João Pedro Ferreira, Christian Bär, et al.Circulation|April 29, 2009
Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) studyWafae Iraqi, Patrick Rossignol, Michael Angioi, et al.Journal of the American College of Cardiology|October 1, 2016
Hyperkalemia in Heart FailureChaudhry M S Sarwar, Lampros Papadimitriou, Bertram Pitt, et al.The New England Journal of Medicine|April 2, 2003
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarctionBertram Pitt, Willem Remme, Faiez Zannad, et al.Journal of the American College of Cardiology|April 28, 2012
Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) studyKarl Swedberg, Faiez Zannad, John J V McMurray, et al.Circulation. Heart Failure|April 30, 2013
Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF studyHenry Krum, Harry Shi, Bertram Pitt, et al.European Journal of Heart Failure|August 9, 2012
Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trialDaniela Dobre, Patrick Rossignol, Jan Murin, et al.Pageof 132